Allyx Therapeutics, Inc. research brief

CIK 1865257 Copy CIK

Generated Nov. 7, 2026, 3:50 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: NEW HAVEN CT. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Oct. 21, 2026 · D/A · 0001865257-26-000005 · Source evidence

  Reported offering amount: 29999999 USD. Reported amount sold: 27927729 USD.

• May 11, 2026 · D · 0001865257-26-000004 · Source evidence

  Reported offering amount: 29999999 USD. Reported amount sold: 26427730 USD.

• March 3, 2026 · D · 0001865257-26-000003 · Source evidence

  Reported offering amount: 4000000 USD. Reported amount sold: 3324918 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Allyx Therapeutics, Inc. research brief,” CIK 1865257, retrieved Nov. 7, 2026, 3:50 p.m.. Cite the specific accessions used. No amounts have been summed.